Synapse - Pedram Razavi

Results (184)

Analysis of estrogen receptor (ER) immunohistochemistry (IHC) in breast cancer with ESR1 mutations detected by hybrid capture-based next generation sequencing (NGS)

Meeting Abstract

Ross, D. S.; Konno, F.; Brogi, E.; Zehir, A.; Berger, M. F.; Chandarlapaty, S.; Razavi, P.; Baselga, J.; Wen, H. Y.
Modern Pathology (2016)

Fulltext@MSK | Save

Analysis of estrogen receptor (ER) immunohistochemistry (IHC) in breast cancer with ESR1 mutations detected by hybrid capture-based next generation sequencing (NGS)

Meeting Abstract

Ross, D. S.; Konno, F.; Brogi, E.; Zehir, A.; Berger, M. F.; Chandarlapaty, S.; Razavi, P.; Baselga, J.; Wen, H. Y.
Laboratory Investigation (2016)

Fulltext@MSK | Save

The clinical utility of ERBB2 amplification detection in breast carcinoma using a 341 gene hybrid capture-based next generation sequencing (NGS) assay: Comparison with standard immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) assays

Meeting Abstract

Ross, D. S.; Zehir, A.; Cheng, D. T.; Nafa, K.; Jour, G.; Razavi, P.; Hyman, D. M.; Baselga, J.; Berger, M. F.; Ladanyi, M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups

Journal Article

Ailawadhi, S.; Swaika, A.; Razavi, P.; Yang, D.; Chanan-Khan, A.
Blood Cancer Journal (2014)

Fulltext@MSK | Save